glp 1 prostate cancer Forced expression of glucagon‐like peptide‐1 receptor (GLP‐1R) In a man with prostate

Willingness to be consistent and build habits: Tesamorelin is not a shortcut

Danazol, an older option, carries androgenic effects like acne, hirsutism, and liver dysfunction

Targeting antioxidants to mitochondria: a new therapeutic direction

With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to review the mode of action of these medications and that of an alternative GLP-1-stimulating nutraceutical

Omega3 polyunsaturated fatty acids inhibit IL11/STAT3 signaling in hepatocytes during acetaminophen hepatotoxicity